دورية أكاديمية
أعرض في EDS

Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.

التفاصيل البيبلوغرافية
العنوان: Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.
المؤلفون: Cedena MT; Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain.; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain., Rapado I; Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain.; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain., Santos-Lozano A; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain.; GIDFYS, European University Miguel de Cervantes, Valladolid, Spain., Ayala R; Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain.; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain., Onecha E; Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain.; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain., Abaigar M; IBSAL, Cancer Research Center (USAL-CSIC), Salamanca, Spain., Such E; Hematology Department, Hospital Universitario La Fe, Valencia, Spain., Ramos F; Hematology Department, Hospital Universitario de León, and IBIOMED, Universidad León, León, Spain., Cervera J; Hematology Department, Hospital Universitario La Fe, Valencia, Spain.; Genetics Unit, Hospital Universitario La Fe, Valencia, Spain., Díez-Campelo M; IBSAL, Cancer Research Center (USAL-CSIC), Salamanca, Spain.; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Sanz G; Hematology Department, Hospital Universitario La Fe, Valencia, Spain., Rivas JH; IBSAL, Cancer Research Center (USAL-CSIC), Salamanca, Spain.; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Lucía A; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain.; Universidad Europea de Madrid, Madrid, Spain., Martínez-López J; Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain.; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain.
المصدر: Oncotarget [Oncotarget] 2018 Jul 20; Vol. 9 (56), pp. 30936. Date of Electronic Publication: 2018 Jul 20 (Print Publication: 2018).
نوع المنشور: Journal Article; Published Erratum
اللغة: English
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Albany, N.Y. : Impact Journals
مستخلص: [This corrects the article DOI: 10.18632/oncotarget.22157.].
التعليقات: Erratum for: Oncotarget. 2017 Oct 27;8(63):106948-106961. (PMID: 29291002)
تواريخ الأحداث: Date Created: 20180817 Latest Revision: 20191120
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6089387
DOI: 10.18632/oncotarget.25856
PMID: 30112119
قاعدة البيانات: MEDLINE
الوصف
تدمد:1949-2553
DOI:10.18632/oncotarget.25856